Yazar "Karabulut, Vahap" seçeneğine göre listele
Listeleniyor 1 - 3 / 3
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Relationship between Suicide Attempt History and Borderline Personality Disorder, Aggression, Impulsivity, and Self-Mutilative Behavior among Male Inpatients with Substance Use Disorder(AVES, BUYUKDERE CAD 105-9, MECIDIYEKOY, SISLI, ISTANBUL 34394, TURKEY, 2021) Karabulut, Vahap; Evren, Cüneyt; Alnıak, İzgi; Çarkcı, Özlem Helin; Umut, Gökhan; Çetin, Turan; Yılmaz Çengel, HanifeObjective: The purpose of this study was to evaluate the relationship between lifetime history of suicide attempt (HSA) and borderline personality disorder (BPD), aggression, impulsivity, and selfmutilative behavior (SMB) in a sample of male inpatients with substance use disorder (SUD). Method: The sample included 132 male inpatients with alcohol or opioid use disorder. The participants were evaluated using the Buss-Perry Aggression Questionnaire, the Short Form of the Barratt Impulsiveness Scale (BIS-11-SF), and a structured clinical interview for DSM-IV Axis II Personality Disorders (SCID-II) for BPD. Results: The mean age was lower in the group with HSA (n = 52, 39.4%) compared to the group without HSA (n = 80, 60.6%), whereas no difference was found between the groups in terms of duration of education, alcohol or opioid use disorder, marital status, and employment status. The rate of BPD and SMB and aggression and impulsivity scores were higher among those with lifetime HSA. According to linear regression analysis, although BPD, anger, and non-planning impulsivity predicted HSA, when SMB was included in the analysis BPD was no longer a predictor. SMB, on the other hand, predicted HSA together with anger and non-planning impulsivity. Conclusion: While BPD and HSA are associated, SMB seems to have a mediating role in this relationship. In addition, anger and non-planning impulsivity may have a partial mediating role in the relationship between BPD and HSA among patients with SUD.Öğe The relationship of alexithymia with difficulty in emotional regulation, anxiety, and depression symptoms in a group of patients receiving opioid maintenance treatment(Pacini Editore, 2021) Karabulut, Vahap; Evren, Cüneyt; Alnıak, İzgi; Çarkcı, Özlem Helin; Yılmaz Çengel, HanifeBackground: The purpose of this study was to evaluate the relationship between alexithymia and emotion regulation difficulties in a group of patients receiving opioid (buprenorphine). Methods: The study was directed to the problems of inpatients in the Alcohol and Substance Dependence Service of Bakirkoy Mental and Nervous Diseases Training and Research Hospital. Data from 90 patients with opioid use disorders were evaluated. The following scales were adminstered to each of the patients participating: the State-Trait Anxiety Inventory I-II (STAI I-II), Beck's Depression Inventory (BDI), Difficulties in Emotion Regulation Scale (DERS), and Toronto Alexithymia Scale (TAS-20). Results: 54.4% of the patients were found to have alexithymia or possible alexithymia. There were no statistically significant differences between those who had alexithymia and those who were free of it in terms of age, years of education, age at first substance use, duration of heroin use, marital status, and employment status. The alexithymic patients scored significantly higher than the non-alexithymic patients on DERS (104.35 +/- 16.70 vs. 77.88 +/- 12.48, p>0.001), STAI-I (37.69 +/- 9.42 vs. 33.15 +/- 6.68, p=0.009), and STAI-II (50.10 +/- 7.27 vs. 40.20 +/- 6.29, p>0.001). The BDI scores (17.81 +/- 12.40 vs. 11.31 +/- 12.90, p=0.056) did not differ significantly between the two groups. The MANCOVA analysis showed that difficulty in identifying feelings as a subdimension of alexithymia was predicted by trait anxiety and the awareness, strategies, and clarity subscales of DERS, and the externally-oriented thinking subdimension of alexithymia was predicted by the awareness subscale of DERS. Linear regression analysis showed that difficulty in emotion regulation (with special reference to clarity, strategies, and goals subscales), taken together with trait anxiety, predicted the severity of alexithymia. Conclusions: Our findings indicate that, in particular, the clarity, strategies, and goal subscales of DERS, along with trait anxiety, are associated with the severity of alexithymia in those with opioid use disorder who are receiving maintenance therapy with buprenorphine.Öğe Reliability and Validity of Turkish Version of DSM-5 Substance Use Scale(TURKIYE SINIR VE RUH SAGLIGI DERNEGI, PK 401, YENISEHIR 06442, Turkiye, 2024) Alçı, Deniz; Sarıkavak, Talat; Evren, Cüneyt; Karabulut, Vahap; Çetin, Turan; Aydemir, Ömer; Dsm-5 Scale Working GroupObjective: This study aims to evaluate the severity of substance use disorders according to the DSM-5 criteria and to show the reliability and validity of the Turkish version of the DSM-5 Substance Use Scale that improved to learn what kind of substances are used. Methods: In this study,54 in or out-patients who met the criteria for any substance use disorder according to DSM-5 and who are receiving treatment in Psychiatry Department of Celal Bayar University Faculty of Medicine and AMATEM department of Bakırköy Prof. Dr. Mahzar Osman Mental Health and Neurology Training and Research Hospital, were included. One hundred volunteers without any mental or physical disease were also recruited as the control group. Beside the DSM-5 Level 2 substance use scale, Addiction Profile İndex was used for concurrent validity. Internal consistency coefficient and item-total correlation analysis were performed for reliability analysis. ROC Analysis was used in the validity analysis. Results: Mean age was 26.97±10.20 years in the study group and 39% of the sample (n=60) were female. 5.6% (n=3) of the patient group were female and 94.4% (n=51) were male. In the control group, 57% (n=57) were female and 43% (n=43) were male. Of the patients diagnosed with substance use disorder (n=54), 88.7% had opiate use disorder, 5.6% had polysubstance use disorder, 5.6% had other (unknown) substance (synthetic cannabinoid) use disorder and 1.8% of patients have cannabis use disorder. The internal consistency of the substance use scale was 0.80 and item-total correlation coefficients were between 0,196- 0,643 (p<0.0001). Coefficient of correlation analysis with API was calculated as r=0.806 (p<0.0001). Conclusion: The results showed that DSM-5 Substance Use Scale is a valid and reliable questionnaire that can be used to measure the progress of different dimensions of alcohol and substance use.
